Detalhe da pesquisa
1.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830208
2.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
3.
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J
; 44(31): 2930-2943, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220093
4.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210743
5.
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Eur Heart J
; 43(23): 2212-2220, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325102
6.
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
Eur Heart J
; 43(48): 5006-5016, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675469
7.
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation
; 149(4): 335-338, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252738
8.
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail
; 12(3): 552-563, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300212
9.
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Eur J Heart Fail
; 26(1): 130-139, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933184
10.
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER Trial.
JACC Asia
; 4(2): 108-118, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38371292
11.
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
J Am Coll Cardiol
; 83(9): 904-914, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418004
12.
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER.
JACC Heart Fail
; 11(1): 76-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599553
13.
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial.
Eur J Heart Fail
; 25(2): 248-259, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597719
14.
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF.
JACC Heart Fail
; 11(5): 569-579, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881396
15.
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status.
JACC Heart Fail
; 11(10): 1380-1393, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294244
16.
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
JACC Heart Fail
; 11(11): 1491-1503, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226448
17.
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
Eur J Heart Fail
; 25(7): 1170-1175, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212168
18.
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
Eur J Heart Fail
; 25(9): 1663-1670, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632711
19.
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HF.
Eur J Heart Fail
; 25(8): 1364-1371, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210608
20.
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
Eur J Heart Fail
; 25(12): 2177-2188, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771274